Large Volume Wearable Injectors Market, 2030 Dublin, Jan.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
23
Large Volume Wearable Injectors Market, 2030

Dublin, Jan. 31, 2019 (GLOBE NEWSWIRE) -- The "Large Volume Wearable Injectors Market (4th Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering.

The report features an extensive study of the current market landscape and the likely future evolution of self-injection devices, over the next twelve years. It specifically lays emphasis on the emergence of patient-centric, convenient, cost-effective and user-friendly wearable drug delivery solutions that are capable of administering large volumes of a drug subcutaneously, in the home-care setting.

One of the key objectives of the report was to estimate the existing market size and potential future growth opportunities for large volume wearable injectors. Based on parameters, such as the number of commercialized devices, number of devices under development, the price of the device and the annual adoption rate, we have provided an informed estimate on the likely evolution of the market over the period 2018-2030. The report also features sales forecasts for the overall large volume wearable injectors market with a detailed market segmentation on the therapeutic area, geographical distribution of the market (North America / Europe / Asia Pacific / RoW), type of device (patch pump / injector and infusion pump / injector) and usability (reusable / disposable). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios namely the conservative, base, and optimistic scenarios, which represent different tracks of the industry's evolution. Key Topics Covered:

1. Preface 1.1. Scope of the Report 1.2. Research Methodology 1.3. Chapter Outlines 2. Executive Summary 3. Introduction 3.1. Chapter Overview 3.2. An Overview of Drug Delivery Devices 3.3. Conventional Parenteral Delivery 3.3.1 Needlestick Injuries 3.3.1.1. Incidence and Cost Burden 3.3.1.2. Prevention of Needlestick Injuries 3.3.1.3. Government Legislations for the Prevention of Needlestick Injuries 3.4. Emergence of Self-Administration Devices 3.4.1. Driving Factors 3.4.1.1. Rising Burden of Chronic Diseases 3.4.1.2. Healthcare Cost Savings 3.4.1.3. Need for Immediate Treatment in Emergency Situations 3.4.1.4. Growing Injectable Drugs Market 3.4.1.5. Rising Focus on Patient Centricity 3.4.1.6. Need for Improving Medication Adherence 3.5. Available Self-Injection Devices 3.5.1. Prefilled Syringes 3.5.2. Pen-Injectors 3.5.3. Autoinjectors 3.5.4. Needle-Free Injectors 3.5.5. Large Volume Wearable Injectors 3.6. Regulatory Considerations 3.6.1. Medical Devices 3.6.2. Drug Device Combinations 3.7. Future Perspectives 4. Large Volume Wearable Injectors: Current Market Landscape 4.1. Chapter Overview 4.2. Large Volume Wearable Injectors: Overall Market Landscape 4.2.1. Large Volume Wearable Injectors for Non-Insulin Drugs: Market Landscape 4.2.2. Large Volume Drug Device Combinations: Market Landscape 4.2.3. Large Volume Wearable Injectors for Non-Insulin Drugs: Analysis of Developers (Devices and Drug Device Combinations) 4.2.4. Large Volume Wearable Injectors for Insulin: Market Landscape 4.2.5. Large Volume Wearable Injectors for Insulin: Analysis of Developers 5. Product Competitiveness Analysis 5.1. Chapter Overview 5.2. Methodology 5.3. Product Competitiveness Analysis 5.3.1. Large Volume Wearable Injectors for Non-Insulin Drugs 5.3.2. Large Volume Drug Device Combinations 5.3.3. Large Volume Wearable Injectors for Insulin 6. Large Volume Wearable Injectors: Key Players 6.1. Chapter Overview 6.2. Large Volume Wearable Injectors for Non-Insulin Drugs: Key Players 6.2.1. Becton Dickinson 6.2.2. Bespak 6.2.3. Insulet 6.2.4. Medtronic 6.2.5. Roche 6.2.6. Sonceboz 6.2.7. Enable Injections 6.2.8. Sensile Medical 6.2.9. SteadyMed Therapeutics 6.2.10. West Pharmaceutical Services 6.2.11. Weibel CDS 6.3.1. CellNovo 6.3.2. CeQur 6.3.3. Debiotech 6.3.4. Eli Lilly 6.3.5. PharmaSens 6.3.6. SOOIL 6.3.7. Tandem Diabetes Care 7. Drug-Device Combinations: Tabulated Profiles 7.1. Chapter Overview 7.2. Apomorphine / ND0701 7.3. Bupivacaine / SMT-301 7.4. Ceftriaxone / sc2Wear Infusor 7.5. Furosemide / sc2Wear Infusor 7.6. Herceptin / Single Use Injector 7.7. Ketorolac / SMT-201 7.8. Levadopa and Carbidopa / ND0612 and ND0901 7.9. Neulasta / Omnipod 7.10. Repatha / Pushtronex System 7.11. Treprostinil / Trevyent 8. Patent Analysis 8.1. Chapter Overview 8.2. Scope and Methodology 8.3. Large Volume Wearable Injectors: Patent Analysis 8.3.1. Analysis by Publication Year 8.3.2. Analysis by Patent Offices Involved 8.3.3. Analysis by CPC Classification 8.3.4. Emerging Areas 8.3.5. Leading Players Based on Number of Patents 8.4. Large Volume Wearable Injectors: Patent Benchmarking Analysis 8.4.1. Analysis by Patent Characteristics 8.4.2. Analysis by Geography 8.5. Large Volume Wearable Injectors: Patent Valuation Analysis 9. Emerging Trends On Social Media 9.1. Chapter Overview 9.2. Large Volume Wearable Injectors: Trends on Twitter 9.2.1. Historical Trend in Volume of Tweets 9.2.2. Trending Words / Phrases Related to Large Volume Wearable Injectors 9.2.3. Most Influential Authors 9.2.4. Popular Players on Twitter 9.2.4.1. Roche (Accu-Chek Solo Micropump System) 9.2.4.2. Cellnovo (Cellnovo Insulin Pump) 9.2.4.3. Insulet (Omnipod) 9.2.4.4. Medtronic (Minimed Wearable Injectors) 9.2.4.5. Comparison of Popular Players Based on Number of Tweets 9.3. Concluding Remarks 10. Clinical Trial Analysis 10.1. Chapter Overview 10.2. Scope and Methodology 10.3. Large Volume Wearable Injectors: Clinical Trial Analysis 11. Case Study: Role of CMOS in Device Development Supply Chain 11.1. Chapter Overview 11.2. Device Development Supply Chain 11.3. Significance of CMOs in the Drug Delivery Device Development Process 11.4. List of Contract Manufacturing Organizations 11.4.1. Contract Manufacturers: Geographical Distribution and Services Offered 12. Large Volume Wearable Injectors: Likely Drug Candidates 12.1. Chapter Overview 12.2. Marketed Drugs 12.2.1. Most Likely Candidates for Delivery via Large Volume Wearable Injectors 12.2.2. Likely Candidates for Delivery via Large Volume Wearable Injectors 12.2.3. Less Likely Candidates for Delivery via Large Volume Wearable Injectors 12.2.4. Unlikely Candidates for Delivery via Large Volume Wearable Injectors 12.3. Clinical Drug Candidates 12.3.1. Biologics 12.3.2. Small Molecules 13. Market Sizing and Opportunity Analysis 13.1. Chapter Overview 13.2. Forecast Methodology and Key Assumptions 14. Future Growth Opportunities 14.1. Chapter Overview 14.2. SWOT Analysis 14.2.1. Strengths 14.2.2. Weaknesses 14.2.3. Opportunities 14.2.4. Threats 14.3. Future Growth Opportunities 15. Executive Insights: Interview Transcripts & Company Snapshot 15.1. Chapter Overview 15.2. Elcam Medical 15.3. Enable Injections 15.4. Medipacs 15.5. Ratio Drug Delivery 15.6. scPharmaceuticals 15.7. Sorrel Medical 15.8. Subcuject 15.9. West Pharmaceutical Services

Companies Mentioned

  • 3M
  • Abbott
  • AbbVie
  • AbGenomics
  • Ablynx
  • Acceleron Pharma
  • Actavis Pharma
  • ADC Therapeutics
  • Adrenomed
  • Aduro BioTech
  • Advaxis
  • Aeglea BioTherapeutics
  • Affibody
  • Affimed
  • Agenus
  • AgonOx
  • Akesobio Australia
  • Alder BioPharmaceuticals
  • Alector
  • Alexion Pharmaceuticals
  • Alkahest
  • Alkermes
  • Allakos
  • Allergan
  • Allozyne
  • Alnylam Pharmaceuticals
  • AlphaCore Pharma
  • Altor BioScience
  • Ambrx
  • amcure
  • Amgen
  • Amicus Therapeutics
  • Amphivena Therapeutics
  • Amplyx Pharmaceuticals
  • Amylin Pharmaceuticals
  • Angiochem
  • Animas
  • Antares Pharma
  • Antaros Medical
  • Aprea Therapeutics
  • Aptevo Therapeutics
  • argenx
  • Argos Therapeutics
  • ArmaGen
  • ARMO BioSciences
  • Aronora
  • Asklepion Pharmaceuticals
  • Astellas Pharma
  • AstraZeneca
  • Atridia
  • AVEO Pharmaceuticals
  • Axon Neuroscience
  • Bang & Olufsen Medicom
  • Baril
  • Basilea Pharmaceutica
  • Battelle
  • Baxter International
  • Bayer
  • Bayhill Therapeutics
  • Becton Dickinson
  • BeiGene
  • Beijing Dongfang Biotech
  • Bespak
  • Bio-Path Holdings
  • Bio-Thera Solutions
  • BioArctic
  • BIOCAD
  • bioCSL
  • Biogen
  • BioIntegrator
  • Bioject Medical Technologies
  • BioMarin Pharmaceutical
  • Bioniz Therapeutics
  • BioNTech
  • Biotest Pharmaceuticals
  • Boehringer Ingelheim
  • Boston Pharmaceuticals
  • Bristol Myers Squibb
  • Calando Pharmaceuticals
  • Calibra Medical
  • CANbridge Life Sciences
  • Cancer Advances
  • Cara Therapeutics
  • Catalyst Biosciences
  • CEL-SCI
  • Celgene
  • Celldex Therapeutics
  • Cellnovo
  • CeQur
  • Chimerix
  • CHO Pharma
  • Chugai Pharmaceutical
  • Cidara Therapeutics
  • Cleveland BioLabs
  • Conjupro Biotherapeutics
  • ContraFect
  • Cour Pharmaceutical Development
  • CSL Behring
  • CSPC Pharmaceutical Group
  • CStone Pharmaceuticals
  • CureTech
  • CytoDyn
  • Daikyo Seiko
  • Datwyler
  • Debiotech
  • DEKA
  • Dekkun
  • Delta-Fly Pharma
  • Dendreon
  • Dexcom
  • DiaMedica Therapeutics
  • Diamyd Medical
  • E3D Elcam Drug Delivery Devices
  • EG-GILERO
  • Eisai
  • Eli Lilly
  • Elusys Therapeutics
  • EMD Serono
  • Emergent BioSolutions
  • Enable Injections
  • Endo Pharmaceuticals
  • Endocyte
  • EnGeneIC
  • EOFlow
  • EpicentRx
  • Eternity Healthcare
  • European Pharma Group
  • F2G
  • Fabrico
  • FibroGen
  • Finox Biotech
  • Five Prime Therapeutics
  • Flex Pharma
  • Flowonix Medical
  • Galaxy Biotech
  • Galena Biopharma
  • Genentech
  • GENERON
  • GeneScience Pharmaceuticals
  • Genexine
  • Genzyme
  • Gerresheimer
  • Gilead Sciences
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Gliknik
  • Guangzhou Cellprotek Pharmaceutical
  • HAL Allergy
  • Halozyme Therapeutics
  • Hanmi Pharmaceutical
  • Haselmeier
  • Helsinn Healthcare
  • Hemispherx Biopharm
  • Hoffmann-La Roche
  • Huabo Biopharm
  • ImClone Systems
  • Immatics Biotechnologies
  • Immune Response BioPharma
  • ImmuneMed
  • ImmunGene
  • Immunocore
  • ImmunoFrontier
  • ImmunoGen
  • Immunomedics
  • Immunotope
  • Immunovaccine
  • Implicit Bioscience
  • Incuron
  • Incyte
  • Injex Pharma
  • Innate Pharma
  • Innovent Biologics
  • Inovio Pharmaceuticals
  • Insulet
  • iNtRON Biotechnology
  • IO Biotech
  • Ionis Pharmaceuticals
  • Ipsen
  • ISU ABXIS
  • Janssen
  • Jerini
  • JHL Biotech
  • Jiangsu Hengrui Medicine
  • Jiangsu T-Mab Biopharma
  • Johnson & Johnson
  • Jounce Therapeutics
  • kaleo
  • KaloBios Pharmaceuticals
  • Kiniksa Pharmaceuticals
  • Kissei Pharmaceutical
  • Kura Oncology
  • Kyowa Hakko Kirin
  • Labrys Biologics
  • Leadiant Biosciences
  • LEO Pharma
  • Levicept
  • Life Science Pharmaceuticals
  • MabVax Therapeutics
  • MacroGenics
  • Medical International Technology
  • MedImmune
  • Medipacs
  • MedPro Safety Products
  • Medtronic
  • Medtrum Technologies
  • Menarini Group
  • Merck
  • Merck Sharp & Dohme
  • Mereo BioPharma
  • Meridian Medical Technologies
  • Merrimack Pharmaceuticals
  • Mersana Therapeutics
  • Merus
  • Merz Pharma
  • Millennium Pharmaceuticals
  • MiNA Therapeutics
  • miRagen Therapeutics
  • Mitsubishi Tanabe Pharma
  • Moderna Therapeutics
  • Molecular Partners
  • Molecular Templates
  • MolMed
  • MorphoSys
  • Morphotek
  • MTD Micro Molding
  • Mylan
  • NantBioScience
  • Naurex
  • Navidea Biopharmaceuticals
  • Neogenix Oncology
  • Neon Therapeutics
  • NeuroDerm
  • Nordic Bioscience
  • Northern Biologics
  • Novartis Pharmaceuticals
  • Novimmune
  • NOVO Engineering
  • Novo Nordisk
  • OBI Pharma
  • Octapharma
  • Omeros
  • Oncology Venture
  • OncoMed Pharmaceuticals
  • OncoPep
  • Oncopeptides
  • Oncternal Therapeutics
  • Oncurious
  • Opthea
  • Optimer Pharmaceuticals
  • OSE Immunotherapeutics
  • Otsuka Pharmaceutical
  • Paion UK
  • Pfizer
  • PharmaJet
  • PharmaMar
  • PharmaSens
  • PhaseBio Pharmaceuticals
  • Phillips-Medisize
  • Philogen
  • Phosplatin Therapeutics
  • Pierre Fabre
  • Pique Therapeutics
  • Polaris Group
  • Polyphor
  • Prescient Therapeutics
  • Prestige BioPharma
  • Promedior
  • Prometheus Laboratories
  • Protalix Biotherapeutics
  • Proven Process Medical Devices
  • Quest PharmaTech
  • Quintessence Biosciences
  • R-Pharm
  • Ratio Drug Delivery
  • RAUMEDIC
  • Recro Pharma
  • Regeneron Pharmaceuticals
  • REMD Biotherapeutics
  • Resolve Therapeutics
  • rEVO Biologics
  • Rhythm Pharmaceuticals
  • Roche
  • Roehr pharmaceuticals
  • Sagentia
  • Samsung Bioepis
  • Sandoz
  • Sanofi
  • Santarus
  • Savient Pharmaceuticals
  • scPharmaceuticals
  • Seattle Genetics
  • Selecta Biosciences
  • Selexys Pharmaceuticals
  • Sensile Medical
  • Serina Therapeutics
  • Shire
  • SMC Global
  • Smiths Medical
  • Sonceboz
  • SOOIL
  • SteadyMed Therapeutics
  • Stealth BioTherapeutics
  • Stemline Therapeutics
  • Stevanato Group
  • Subcuject
  • Sumitomo Dainippon Pharma
  • Sunovion Pharmaceuticals
  • SymBio Pharmaceuticals
  • Symphogen
  • Synectics
  • Synermore Biologics
  • Syntimmune
  • Syros Pharmaceuticals
  • TaiMed Biologics
  • Taiwan Liposome Company
  • Takeda Pharmaceutical
  • Tandem Diabetes Care
  • Tanvex BioPharma
  • Tarveda Therapeutics
  • Teva Pharmaceutical
  • TG Therapeutics
  • Tolero Pharmaceuticals
  • TRACON Pharmaceuticals
  • Translational Sciences
  • Turnstone Biologics
  • United BioPharma
  • Vaccinex
  • Vaccinogen
  • Valtronic
  • vasopharm BIOTECH
  • Verily Life Sciences
  • Vetter Pharma
  • ViCentra
  • Viela Bio
  • ViiV Healthcare
  • Visterra
  • Vitaeris
  • Vivozon
  • Weibel CDS
  • West Pharmaceutical Services
  • Wockhardt
  • Xbiotech
  • Xencor
  • XOMA
  • Ypsomed
  • Zafgen
  • Zollner

For more information about this report visit https://www.researchandmarkets.com/research/r...olume?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Infusions and Injectables , Needles and Syringes

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cabot Wilds: Nova Scotia's Next Luxury Golf Haven

Updated Category News Views 7

Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...

Continue Reading
WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 3

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 10

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading
MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Updated Category News Views 10

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 8

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 6

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 4

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 5

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
More News Articles

Top 5 Most Recently Viewed Articles

Aggressive Growth Seen in Agricultural Films

Updated Category News Views 15

Digging Into The Agricultural Films Boom Let’s start from the soil here—agricultural films might not be the flashiest subject, but with a market expected to hit $21.6 billion by 2031, this sector is cultivating a hefty growth. The backbone of this surge? The skyrocketing demand for innovative farming methods that respond to population growth and climatic challenges....

Continue Reading
Investigation Launched for Paycor HCM, Inc. Shareholders' Rights

Updated Category News Views 206

Investigation into Paycor HCM, Inc. Shareholder Rights Ademi LLP has initiated an investigation concerning Paycor HCM, Inc. (NASDAQ: PYCR) as part of its commitment to protecting shareholders' interests. This inquiry focuses on potential breaches of fiduciary duty and other legal concerns regarding its recent transaction with Paychex. Shareholder Concerns In the proposed...

Continue Reading
HyperLight Corporation Secures $37M Investment for Growth

Updated Category News Views 124

HyperLight Corporation Secures Major Investment for Growth HyperLight Corporation, well-known for its pioneering efforts in photonic integrated circuits (PICs), has successfully completed a Series B funding round, raising an impressive $37 million. This round was spearheaded by Summit Partners, a firm recognized for its strategic placements in rapidly expanding technology...

Continue Reading
Trump Media’s Shares Surge Amid White House Election Buzz

Updated Category News Views 37

Surge in Trump's Media Company Shares Shares of Trump Media & Technology Group have recently seen a remarkable surge, reaching the highest values not observed since July. The increase comes as optimism grows regarding the chances of former U.S. President Donald Trump in his bid for reelection. Stock Performance and Market Sentiment The stock of Trump Media, known for...

Continue Reading
Cizzle Bio's Groundbreaking Blood Test for Early Gastric Cancer Detection

Updated Category News Views 158

Revolutionizing Gastric Cancer Detection with DEX-G2 Cizzle Bio has achieved a significant breakthrough in the field of cancer diagnostics with its DEX-G2 blood test. Validated through a multicenter clinical study published in a respected medical journal, this innovative liquid biopsy shows remarkable promise in detecting gastric cancer, one of the most lethal forms of...

Continue Reading